Press Releases - 2023-09-13

Date	Title	Company
13-Sep-2023	Redesigning Triumph: Flow Diverters Market Envisioned to Grow to US$ 1.3 Billion by 2032, per FMI	MARKITWIRED
13-Sep-2023	Comprehensive Care for Hearts: The Cardiac Rehabilitation Market at an average CAGR of 6.0% between 2022 and 2032 \| FMI	MARKITWIRED
13-Sep-2023	Novo Nordisk conducts a two-for-one stock split	Novo Nordisk
13-Sep-2023	Interim Report for the period ended 30 June 2023	RTW Biotech Opportunities Ltd
13-Sep-2023	TME Pharma N.V. : NOX-A12 Combination Regimen With Bevacizumab: 17-Month Survival Rate Exceeds All Relevant Competitor Treatments Against Most Severe Form of Adult Brain Cancer	Businesswire
13-Sep-2023	AbbVie's SKYRIZI® (risankizumab) Met All Primary and Secondary Endpoints Versus Stelara® (ustekinumab) in Head-to-Head Study in Crohn's Disease	AbbVie
13-Sep-2023	Veterinary Orthopedics Market: The Road to a US$ 1.5 Billion Industry by 2032, Covering a Range of Species from Equines to Canines \| FMI	MARKITWIRED
13-Sep-2023	Strategic Advancements in Osteoporosis Care: FMI’s Exploration of the US$ 1.7 Billion Bone Densitometers Market Projected by 2032	MARKITWIRED
13-Sep-2023	MedinCell: reporting of the Annual General Meeting	Businesswire
13-Sep-2023	Surgical Snares Market Transformation: FMI’s Forecast for a US$ 3.8 Billion Industry by 2032	MARKITWIRED
13-Sep-2023	Biotech Breakthroughs: Navigating the Path to 8.3% CAGR Growth in Research Antibodies by 2032	MARKITWIRED
13-Sep-2023	Cartilage Repair Market Primed for Unprecedented Growth: FMI Survey Anticipates 13.9% CAGR through 2032	MARKITWIRED
13-Sep-2023	ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products	Synaffix B.V.,
13-Sep-2023	Ad Scientiam Launches International Study to Assess Disability Progression in multiple sclerosis with MSCopilot®	Ad Scientiam
13-Sep-2023	Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)	Moberg Pharma AB
13-Sep-2023	Dental Practice Management Software Market: Empowering Dental Excellence, Envisions US$ 6.74 Billion Valuation by 2033	MARKITWIRED
13-Sep-2023	Interim results for the six months to 30 June 2023	Poolbeg Pharma plc
13-Sep-2023	Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advance	Mainz BioMed N.V.
13-Sep-2023	Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock	Businesswire
13-Sep-2023	United States Concierge Medicine Market: Crafting Customized Wellness, Poised to Reach US$ 17.97 Billion by 2033	MARKITWIRED